Submissions

Online Submissions

Already have a Username/Password for The Indonesian Biomedical Journal?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

 

Author Guidelines

1.    GENERAL TERMS

The Indonesian Biomedical Journal welcomes articles covering all aspects of biomedical sciences. All submitted manuscripts must not previously published and not under consideration for publication elsewhere. Papers may come from any country but must be written in English. Manuscript may be submitted as review articles, research articles, and short communications. There is no submission and processing charges for this journal.

All manuscripts are subjected to peer review. All submissions must be accompanied by abstracts of the authors' manuscripts on related subjects that are in press or under editorial review. Electronic reprints of related published papers by the author/s or manuscripts in press also may be helpful to the reviewers.

All manuscripts must be accompanied by a covering letter signed by all author/s. Upon acceptance, author/s must transfer copyright to the Prodia Education and Research Institute (PERI). Accepted papers become permanent property of PERI and may not be reproduced by any means, in whole or in part, without the written consent from PERI. It is the author/s' responsibility to obtain permission to reproduce illustrations, tables, etc. from other publication.

 

2.    HOW TO SUBMIT

Authors are required to submit manuscripts electronically by using online journal system inabj.org or by sending e-mail to: secretariat@inabj.org. Alternatively authors can submit manuscripts by sending softcopy in a CD to: Secretariat of The Indonesian Biomedical Journal Prodia Tower 9th Floor, JI. Kramat Raya No.150, Jakarta 10430, Indonesia.

 

3.    REQUIREMENTS OF EACH MANUSCRIPT TYPE

  • Review Article: Only for invited authors. Review Article should consist of no more than 10,000 words, not including the words in abstract, references, table, figure, and figure legend. The manuscript should have no more than six figures and/or tables in total and no more than 250 references.
  • Research Article: Research Article should consist of no more than 3,500 words, not including the words in abstract, references, table, figure, and figure legend. The manuscript should have no more than six figures and/or tables in total and no more than 40 references.
  • Short Communication: Only for invited authors. Short Communication should be 750 words or less, not including the words in abstract, reference list, table, figure and figure legend. Either one figure or one table may be included. References are limited to no more than 10 references.

 

4. ABSTRACT

Provide an abstract of no more than 300 words (for Review Articles) or 250 words (for Research Articles and Short Communication). Structured-abstract should be followed in writing any type of Articles.


5. REFERENCES

  • References should be according to the Vancouver system.
  • List all authors when there are six or fewer; when there are seven or more, list the first six, followed by "et al.".
  • Sequential number of references in main text. Please follow in detail all examples below:

Article:
Sandra F, Esposti MD, Ndebele K, Gona P, Knight D, Rosenquist M, et al. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Alters Mitochondrial Membrane Lipids. Cancer Res. 2005; 65: 8286-97.

Book:
Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.

Chapter in a book:
Rosenberg GA. Matrix metalloproteinase and proteolytic opening of the blood brain-barrier in neuroinflamation. In: deVries E, Prat A, editors. The Blood-brain Barrier and Its Microenvironment Basic Physiology To Neurological Disease. New York: Taylor and Francis Group; 2005. p.335-58.

Dissertation/ Thesis/ Essay:
Arlauckas SP. Near infrared fluorescent choline kinase alpha inhibitors for cancer imaging and therapy [Dissertation]. Philadelphia: University of Pennsylvania; 2015.

Part of Website/Monograph:
Medline Plus [Internet]. Bethesda: US National Library of Medicine; ©2009. Diabetic Kidney Problems [update 2015 Nov 2; cited 2015 Nov 16]. Available from: https://www.nlm.nih.gov/medlineplus/diabetickidneyproblems.html/.

Conference Paper:
Fledelius HS. Myopia and significant visual impairment: global aspects. In: Lin LLK, Shin YF, Hung PT, editors. Myopia Updates II: Proceedings of the 7th International Conference on Myopia 1998 Nov 17-20, Taipei. Tokyo: Springer; 2000. p.3-17.

 

6. UNIT OF MEASUREMENT

  • Authors can express all measurements in Conventional or International System (SI) units.
  • Drug names must use generic names. When proprietary brands are used in research, include the brand name, the name and location (city & country) of the manufacturer in parentheses after the first mention of the generic name.
 

7. MANUSCRIPT TEMPLATE

You can use templates below for submitting manuscript to The Indonesian Biomedical Journal.


 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration.
  2. Proof of permission was obtained to reproduce illustrations, tables, etc. from other publication.
  3. The submission file is in Microsoft Word file (.doc/x). Formatted as standard A4 page setup.
  4. The text should be double-spaced with 1-inch margin on the left and right sides. Use 12-point Times New Roman font.
  5. Running title provided (not more than 8 words).
  6. Complete information about author/s (first, middle, last name), author/s's affiliation, and email address of corresponding author.
  7. All pages are numbered at bottom right.
  8. Abstract and Keywords.
    • Review article: ≤300 words
    • Research article: ≤250 words
    • Short communications: ≤250 words
  9. Order Manuscript Body (Introduction, Methods, Results, Conclusions,References, Acknowledgement, Figures and Tables).
    • Review article: ≤10,000 words
    • Research article: ≤3,500 words
    • Short communications: ≤750 words
  10. For review article, no more than 8 figures and/or tables in total; for research article, no more than 6 figures and/or tables in total; and as for short communication, no more than 1 figure or table. Tables are drawn without vertical lines.
  11. Decimal fraction is written in English version (for thousand use point (,) and decimal use comma (.)).
  12. References must be according to the Vancouver Systems. Where available, URLs for the references have been provided.
    • Review article: ≤250 references
    • Research article: ≤40 references
    • Short communications: ≤10 references

  13. Authors can express all measurements in Conventional or International System (SI) units. Drug names must use generic names. When proprietary brands are used in research, include the brand name, the name and location (city & country) of the manufacturer in parentheses after the first mention of the generic name.

 

Copyright Notice

For the submission of a manuscript to The Indonesian Biomedical Journal, author/s has/have to certify that:

1.  I have been granted authorization by my co-author/s to enter into these arrangements.

2.  I hereby declare, on behalf of myself and my co-author/s, that:
  • The manuscript submitted is an original work and has neither been published in any other peer-reviewed journal nor is under consideration for publication by any other journal. More so, the work has been carried out in the author/s’ lab and the manuscript does not contravene any existing copyright or any other third party rights.
  • I am/we are the sole author/s of the manuscript and maintain the authority to enter into this agreement and the granting of rights to the publisher: the Prodia Education and Research Institute (PERI), does not infringe any clause of this agreement.
  • The manuscript contains no such material that may be unlawful, defamatory, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the agreement.
  • I/we have taken due care that the scientific  knowledge and all other statements contained in the manuscript conform to true facts and authentic formulae and will not, if followed precisely, be detrimental to the user.
  • I/we permit the adaptation, preparation of derivative works, oral presentation or distribution, along with the commercial application of the work.
  • No responsibility is assumed by InaBJ and PERI, its staff or members of the editorial boards for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products instruction, advertisements or ideas contained in a publication by InaBJ.


Copyright:

Author/s who publish in any InaBJ print & online journal will transfer copyright to their work to PERI.  Submission of a manuscript to the respective journals implies that all author/s have read and agreed to the content of the Covering Letter or the Terms and Conditions.  It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the manuscript for publication the author/s agree that the publishers have the legal right to take appropriate action against the author/s, if plagiarism or fabricated information is discovered. By submitting a manuscript, the author/s agree that the copyright of their manuscript is transferred to PERI, if and when the manuscript is accepted for publication.  Once submitted to the journal, the author/s will not withdraw their manuscript at any stage prior to publication.  However, the copyright will be released to author/s when the manuscript is rejected.

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.